Lung Cancer,SCLC (Small Cell Lung Cancer) ATZ-TBP Shows Favorable Benefit-risk Profile In Extensive-Stage SCLC Nov 17, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Proves Effective In Advanced NSCLC Patients With METex 14 Mutations Nov 16, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Cabozantinib Shows Improved Outcomes Vs. Placebo For Advanced NET Nov 16, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tepotinib + Osimertinib in EGFR-Mutant NSCLC With MET Amplification After 1L Osimertinib Nov 15, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Multisite SBRT + Ipilimumab + Nivolumab Is Well-Tolerated In First Line Metastatic NSCLC Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dendritic Cell Immunotherapy Vs. Best Supportive Care As A Maintenance Treatment In UPM Patients Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Lazertinib Is Effecive In NSCLC Patients With Uncommon EGFR Mutations Nov 14, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Carboplatin, Etoposide, Bevacizumab, And Atezolizumab Regimen Well Tolerated In ES-SCLC Patients Nov 09, 2023
